NYX-2925, CAS [[2012536-16-0]]

Produktübersicht

• Artikelname: NYX-2925, CAS [[2012536-16-0]]
• Artikelnummer: MCE-HY-135741
• Hersteller Artikelnummer: HY-135741
• Alternativnummer: MCE-HY-135741-50MG,MCE-HY-135741-1MG,MCE-HY-135741-10MG,MCE-HY-135741-100MG,MCE-HY-135741-10MMX1ML,MCE-HY-135741-25MG,MCE-HY-135741-5MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

NYX-2925 is an orally active NMDAR modulator. NYX-2925 restores levels of activated Src and Src phosphorylation sites on GluN2A and GluN2B in the mPFC. NYX-2925 shows no effect on CAMKII, and any addictive or sedative/ataxic side effects. NYX-2925 can be used for research of a variety of NMDA receptor-mediated central nervous system disorders[1][2].

Produkteigenschaften

• Molekulargewicht: 297.35
• Reinheit: 98.77
• CAS Nummer: [2012536-16-0]
• Formel: C14H23N3O4
• Target-Kategorie: iGluR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound